Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wearable Device Monitoring in COPD Patients on Dual Bronchodilator and Rehab
NCT03364829Phase 4Unknown
- Sponsor
- Taipei Medical University Shuang Ho Hospital
- Start
- Jan 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indacaterol + glycopyrronium in chronic obstructive pulmonary disease (COPD), sponsored by Taipei Medical University Shuang Ho Hospital. Status: unknown.
02
Drugs
indacaterol + glycopyrronium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03364829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03364829.